menu
Monday, April 16, 2007
Lavipharm S.A. - Share Capital Increase
Wednesday, August 30, 2006
Lavipharm's imminent entry in the US market opens new horizons for the Group
Monday, August 7, 2006
FDA Approval to Lavipharm's Fentanyl Patch
Tuesday, June 27, 2006
Lavipharm's Trinipatch™ enters the Canadian market
Monday, July 4, 2005
Licensing agreement signed between Lavipharm and Recordati
Thursday, April 15, 2004
Lavipharm: A Strategic Decision in the R&D Area of SCF Technology
Tuesday, April 10, 2003
Lavipharm Corp. (a member of the Lavipharm Group) has entered into a Research Collaboration and License arrangement with GlaxoSmithKline to further the applications of Supercritical Fluids (SCF) to Drug Delivery
Friday, March 28, 2003
LAVIPHARM ANNOUNCES TERMINATION OF MERGER AGREEMENT
Thursday, March 20, 2003
Solid Gel: Innovative Technology by Lavipharm
Wednesday, October 30, 2002
ZONAGEN, INC. AND LAVIPHARM CORP. SIGN DEFINITIVE MERGER AGREEMENT
Tuesday, May 28, 2002
Lavipharm Corp. Enters Into a Collaboration With Akzo-Nobel Subsidiary, Intervet Pharma R&D SA
Thursday, March 28 , 2002
Lavipharm Launches First Anti-Wrinkle Patch In Japan
Tuesday, March 5 , 2002
Lavipharm Corp. Enters Into a Collaboration With Pike Corporation
Tuesday, December 4, 2001
Lavipharm Corp. Enters Into Agreement With Kobe Steel, Ltd For Business Development in Japan
Monday, October 1, 2001
Lavipharm Corp. Enters Into a Collaboration With Bio Sidus S.A.
Thursday, June 21, 2001
Lavipharm Corp. Flemington Pharmaceutical Enter Into Agreement For Feasibility Studies
Sunday, June 10, 2001
Lavipharm Corp. Appears on Alexander Haig’s World Business Review TV Series
Tuesday, December 5, 2000
Lavipharm Laboratories Inc., Acquires Exclusive Rights to Phasex Corporation
Thursday, October 5, 2000
Lavipharm Laboratories Inc. to Acquire Separex
Thursday, October 5, 2000
Lavipharm Laboratories Inc. Adds New Research Facilities